These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36102413)

  • 1. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
    Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
    Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
    Coelho RA; Brito-Santos F; Figueiredo-Carvalho MHG; Silva JVDS; Gutierrez-Galhardo MC; do Valle ACF; Zancopé-Oliveira RM; Trilles L; Meyer W; Freitas DFS; Almeida-Paes R
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
    de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
    Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi.
    Coelho RA; Almeida-Silva F; Figueiredo-Carvalho MHG; Rabello VBS; de Souza GR; Lourenço MCDS; Rodrigues ML; Almeida-Paes R
    Med Mycol; 2024 Mar; 62(4):. PubMed ID: 38533658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J; Li R; Zhang M; Liu L; Wan Z
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus Fonsecaea monophora.
    Xiao X; Li Y; Lan Y; Zhang J; He Y; Cai W; Chen Z; Xi L; Zhang J
    Microbiol Res; 2021 Mar; 244():126668. PubMed ID: 33359842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.
    Tan H; Xu Y; Lan XM; Wu YG; Zhou CJ; Yang XC
    Mycopathologia; 2015 Jun; 179(5-6):447-52. PubMed ID: 25575792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O; León-Cachón RB; Pérez-Maya AA; Aguirre-Garza M; Moreno-Treviño MG; González GM
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Samaddar A; Mendonsa JM; Sudhaharan S; S N; Kindo AJ; Shetty A; Pamidimukkala U
    Microbiol Spectr; 2024 Aug; 12(8):e0078124. PubMed ID: 38920376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
    Zhang J; Wu X; Li M; Huang J; Yin S; Huang H; Lu C; Xi L
    Rev Inst Med Trop Sao Paulo; 2019 Jun; 61():e31. PubMed ID: 31241660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E; Pastor FJ; Mayayo E; Hernández P; Guarro J
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.